166 related articles for article (PubMed ID: 30107717)
1. [Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor].
Du ZG; Wang LY; Zhou Y; Wan HY; Liang FQ; Lyu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):827-832. PubMed ID: 30107717
[No Abstract] [Full Text] [Related]
2. [Analysis on polymorphism at -509 C/T site of TGF-β1 gene in patients with keloids].
Song M; Liu Y
Zhonghua Shao Shang Za Zhi; 2014 Dec; 30(6):482-6. PubMed ID: 25608783
[TBL] [Abstract][Full Text] [Related]
3. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
4. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
5. Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.
Fontein DB; Houtsma D; Nortier JW; Baak-Pablo RF; Kranenbarg EM; van der Straaten TR; Putter H; Seynaeve C; Gelderblom H; van de Velde CJ; Guchelaar HJ
Breast Cancer Res Treat; 2014 Apr; 144(3):599-606. PubMed ID: 24590773
[TBL] [Abstract][Full Text] [Related]
6. Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.
Friesenhengst A; Pribitzer-Winner T; Miedl H; Pröstling K; Schreiber M
Horm Cancer; 2018 Apr; 9(2):128-138. PubMed ID: 29363090
[TBL] [Abstract][Full Text] [Related]
7. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
8. Association of Single Nucleotide Polymorphisms in the CYP19A1 Gene with Female Pattern Hair Loss in a Chinese Population.
Rui W; Sheng Y; Hu R; Miao Y; Han Y; Guo X; Qi S; Xu F; Xu J; Yang Q
Dermatology; 2015; 231(3):239-44. PubMed ID: 26228318
[TBL] [Abstract][Full Text] [Related]
9. Positive association of polymorphisms in estrogen biosynthesis gene, CYP19A1, and metabolism, GST, in breast cancer susceptibility.
Ramalhinho AC; Fonseca-Moutinho JA; Breitenfeld Granadeiro LA
DNA Cell Biol; 2012 Jun; 31(6):1100-6. PubMed ID: 22300440
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
[TBL] [Abstract][Full Text] [Related]
11. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
12. Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.
Miron L; Negură L; Peptanariu D; Marinca M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):997-1004. PubMed ID: 23700878
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
BMC Med Genet; 2019 Sep; 20(1):148. PubMed ID: 31477036
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
Cai Q; Kataoka N; Li C; Wen W; Smith JR; Gao YT; Shu XO; Zheng W
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):27-32. PubMed ID: 18199708
[TBL] [Abstract][Full Text] [Related]
15. [Effect of R264C polymorphism in CYP19A1 gene on BRCA1/2-negative hereditary breast cancer from Shanghai population of China].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):181-3. PubMed ID: 16604491
[TBL] [Abstract][Full Text] [Related]
16. Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.
Artigalás O; Vanni T; Hutz MH; Ashton-Prolla P; Schwartz IV
BMC Med; 2015 Jun; 13():139. PubMed ID: 26067721
[TBL] [Abstract][Full Text] [Related]
17. [Association between single nucleotide polymorphism of rs2252673 of INSR gene and polycystic ovarian syndrome].
Du J; Wang Z; Zhang J; Jia L; Zhang F; Shi Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):919-24. PubMed ID: 25608993
[TBL] [Abstract][Full Text] [Related]
18. Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.
Straume AH; Knappskog S; Lønning PE
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):69-75. PubMed ID: 21939764
[TBL] [Abstract][Full Text] [Related]
19. The
Lv F; Huang W; Wang Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):486-495. PubMed ID: 34280004
[No Abstract] [Full Text] [Related]
20. [Correlation between TCF7L2 gene polymorphism and genetic susceptibility in women with gestational diabetes mellitus].
Shi X; Cai Q; Zou M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):588-93. PubMed ID: 25354859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
